JPS6365649B2 - - Google Patents

Info

Publication number
JPS6365649B2
JPS6365649B2 JP1145680A JP1145680A JPS6365649B2 JP S6365649 B2 JPS6365649 B2 JP S6365649B2 JP 1145680 A JP1145680 A JP 1145680A JP 1145680 A JP1145680 A JP 1145680A JP S6365649 B2 JPS6365649 B2 JP S6365649B2
Authority
JP
Japan
Prior art keywords
group
polyorganosilsesquioxane
formula
nhch
reaction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP1145680A
Other languages
English (en)
Japanese (ja)
Other versions
JPS56110622A (en
Inventor
Kyohiko Yoshitani
Juichi Miura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tokuyama Corp
Original Assignee
Tokuyama Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tokuyama Corp filed Critical Tokuyama Corp
Priority to JP1145680A priority Critical patent/JPS56110622A/ja
Publication of JPS56110622A publication Critical patent/JPS56110622A/ja
Publication of JPS6365649B2 publication Critical patent/JPS6365649B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP1145680A 1980-02-04 1980-02-04 Carcinostatic agent Granted JPS56110622A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP1145680A JPS56110622A (en) 1980-02-04 1980-02-04 Carcinostatic agent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP1145680A JPS56110622A (en) 1980-02-04 1980-02-04 Carcinostatic agent

Publications (2)

Publication Number Publication Date
JPS56110622A JPS56110622A (en) 1981-09-01
JPS6365649B2 true JPS6365649B2 (enrdf_load_stackoverflow) 1988-12-16

Family

ID=11778589

Family Applications (1)

Application Number Title Priority Date Filing Date
JP1145680A Granted JPS56110622A (en) 1980-02-04 1980-02-04 Carcinostatic agent

Country Status (1)

Country Link
JP (1) JPS56110622A (enrdf_load_stackoverflow)

Also Published As

Publication number Publication date
JPS56110622A (en) 1981-09-01

Similar Documents

Publication Publication Date Title
JP3499905B2 (ja) グアニジンアルキル−１，１−ビスホスホン酸誘導体、その製法およびその使用
US4271084A (en) Germanium-containing organic polymer and the process for the production of the same
JP2000511203A (ja) ピラジン化合物
JP2848527B2 (ja) キノロンカルボン酸溶液
KR20090024212A (ko) 포스핀 전이 금속 착체, 그의 제조 방법 및 항암제
JP3119738B2 (ja) Ｎ−フェニル−２−シアノ−３−ヒドロキシクロトンアミド誘導体および免疫調整性を有する医薬品としてのその使用
JP2618578B2 (ja) 医 薬
JPS5920266A (ja) 乾癬治療に便利なアルフア−ポリオレフイン性カルボン酸とそれらの誘導体
AU762988B2 (en) "Novel aminoalkanesulphonic acid derivatives, their production and their use as medicaments"
JPS6365649B2 (enrdf_load_stackoverflow)
AU596577B2 (en) Polyprenyl compounds
US5281588A (en) Organometallic compounds, methods for their preparation and pharmaceutical compositions containing them
JPH10251285A (ja) 白金（ｉｖ）錯体及びこれを含有する医薬
US4206231A (en) Hypoglycaemically active 2-alkyl- or -alkenyl-hydrazono propionic acid derivatives
JPS5918399B2 (ja) 有機ゲルマニウム重合体の製造方法
US3851057A (en) Dextran derivatives for the reduction of blood lipids
JP3125101B2 (ja) 光学異性ヒダントインの分割方法
JP7345167B2 (ja) ポリ（カルバメート）－核酸医薬コンジュゲート、ポリ（カルバメート）核酸医薬コンジュゲートの凝集粒子、及び凝集粒子の製造方法
JPH061720A (ja) 抗炎、抗潰瘍剤
US6781011B2 (en) Bis-H-phosphinic acid derivatives as precursors to therapeutic bisphosphonates and uses thereof
WO2001032650A2 (en) Alkaline salts of n-(6-alkyl-2,4-dioxo-1,2,3,4-tetrahydro-5-pyrimidinesulfone)-n'-isonicotinoylhydrazide, possess for their preparation, and pharmaceutical composition based on these salts
KR850000210B1 (ko) 옥사졸린의 제조방법
JPH0432825B2 (enrdf_load_stackoverflow)
JPS6365648B2 (enrdf_load_stackoverflow)
EP0025965A2 (en) Organogermanium compounds, a method for producing them and pharmaceutical compositions comprising them